2019
HPV Vaccine in Adolescents.
Braverman P. HPV Vaccine in Adolescents. Pediatric Annals 2019, 48: e71-e77. PMID: 30747983, DOI: 10.3928/19382359-20190118-02.ChaptersConceptsHuman papillomavirusHPV vaccineVaccination ratesMeningococcal conjugate vaccineHPV vaccination ratesProphylactic HPV vaccinesAge 15 yearsAdolescent vaccinesHPV prevalenceAcellular pertussisFirst doseConjugate vaccineOropharyngeal cancerAnogenital cancersCervical cancerUS registryClinician recommendationsViral infectionDisease endpointsYounger ageVaccineHigh titersCancerCausative agentVaccination
2013
Anal Human Papillomavirus Infection Among HIV-Infected and Uninfected Men Who Have Sex With Men in Beijing, China
Hu Y, Qian HZ, Sun J, Gao L, Yin L, Li X, Xiao D, Li D, Sun X, Ruan Y, Milam DF, Pan SW, Shao Y, Vermund SH. Anal Human Papillomavirus Infection Among HIV-Infected and Uninfected Men Who Have Sex With Men in Beijing, China. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2013, 64: 103-114. PMID: 23732908, PMCID: PMC3780393, DOI: 10.1097/qai.0b013e31829b6298.Peer-Reviewed Original ResearchConceptsHuman papillomavirusHPV infectionUninfected menAnal intercourseAnal human papillomavirus (HPV) infectionUnprotected receptive anal intercourseAnal human papillomavirusHPV anal infectionOncogenic HPV prevalenceHuman papillomavirus infectionMultivariable logistic analysisReceptive anal intercourseInterviewer-administrated questionnaireReceptive anal sexInsertive anal intercourseHPV prevalenceHPV vaccinationUninfected MSMUninfected participantsAnal infectionPapillomavirus infectionSyphilis serologyAnal specimensHIV prevalenceHealth workers
2001
Viral latency--the papillomavirus model.
Broker TR, Jin G, Croom-Rivers A, Bragg SM, Richardson M, Chow LT, Vermund SH, Alvarez RD, Pappas PG, Squires KE, Hoesley CJ. Viral latency--the papillomavirus model. 2001, 106: 443-51; discussion 452-3, 465-75. PMID: 11761260.Peer-Reviewed Original ResearchConceptsHPV typesHPV DNAAIDS cohortEnd-stage renal failureCervico-vaginal lavageKidney transplantation candidatesConsequence of immunosuppressionHuman papillomavirus infectionLower genital tractDifferent HPV typesLatent viral infectionFunctional immune systemHIV/AIDSSub-clinical stateHPV prevalenceHIV cohortHPV infectionKidney transplantationNested polymerase chain reaction amplificationPapillomavirus infectionRenal failureTransplantation candidatesHPV 6Immune depressionImmunosuppressive conditions
1997
Comparison of PCR and hybrid capture methods for detection of human papillomavirus in injection drug-using women at high risk of human immunodeficiency virus infection
Shah K, Solomon L, Daniel R, Cohn S, Vlahov D. Comparison of PCR and hybrid capture methods for detection of human papillomavirus in injection drug-using women at high risk of human immunodeficiency virus infection. Journal Of Clinical Microbiology 1997, 35: 517-519. PMID: 9003632, PMCID: PMC229616, DOI: 10.1128/jcm.35.2.517-519.1997.Peer-Reviewed Original ResearchConceptsHuman papillomavirusHybrid captureInjection drug-using womenHuman immunodeficiency virus (HIV) infectionL1 consensus primersHIV-negative womenImmunodeficiency virus infectionPap smear abnormalitiesHuman immunodeficiency virusDrug-using womenHPV prevalencePositive womenSmear abnormalitiesImmunodeficiency virusViral loadHybrid capture methodVirus infectionHigh riskComparison of PCRLow specificityConsensus primersWomenPapillomavirusPCRInfection
1996
Declining Prevalence of Cervicovaginal Human Papillomavirus Infection With Age Is Independent of Other Risk Factors
BURK R, KELLY P, FELDMAN J, BROMBERG J, VERMUND S, DEHOVITZ J, LANDESMAN S. Declining Prevalence of Cervicovaginal Human Papillomavirus Infection With Age Is Independent of Other Risk Factors. Sexually Transmitted Diseases 1996, 23: 333-341. PMID: 8836027, DOI: 10.1097/00007435-199607000-00013.Peer-Reviewed Original ResearchConceptsPrevalence of HPVHuman papillomavirus infectionHPV infectionPapillomavirus infectionRisk factorsCervicovaginal human papillomavirus infectionGenital HPV infectionCervical HPV infectionWomen 45 yearsFemale genital tractLogistic regression analysisYears of ageSexual behaviorInner-city womenAge-dependent declineHPV immunityHPV prevalenceCervical diseaseCervicovaginal cellsGenital tractLow prevalenceOlder womenSex partnersYounger ageBiologic effects
1995
Prevalence of Human Papillomavirus Among STD Clinic Attenders in Jamaica
FIGUEROA J, WARD E, LUTHI T, VERMUND S, BRATHWAITE A, BURK R. Prevalence of Human Papillomavirus Among STD Clinic Attenders in Jamaica. Sexually Transmitted Diseases 1995, 22: 114-118. PMID: 7624812, DOI: 10.1097/00007435-199503000-00007.Peer-Reviewed Original ResearchConceptsHuman papillomavirus infectionHuman papillomavirusPapillomavirus infectionSTD clinicOlder womenHigh HPV prevalenceHuman papillomavirus (HPV) prevalencePrevalence of HPVSTD clinic attendersIncidence of cancerMajor etiologic agentHuman papillomavirus (HPV) genomeLow-stringency Southern blot hybridizationCross-sectional surveyHPV prevalenceEffect of ageClinic attendersCervical cancerWomen 25Risk factorsWomen 20Effective vaccineLow prevalenceWomen 15Etiologic agent
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply